Gilead Sciences, Inc. Portfolio Stock Holdings
Gilead Sciences, Inc. disclosed 5 stock positions valued at approximately $1.6 billion in its latest SEC 13F filing. The largest holdings include Arcus Biosciences Inc., Lakefront Biotherapeutics, and Assembly Biosciences Inc.. The filing reflects positions held as of June 30, 2026 and was filed on August 3, 2026.
- Report Period
- June 30, 2026
- No. of Stocks
- 5
- Portfolio Value
- $1.6B
Holdings by Sector
Gilead Sciences, Inc. Portfolio Holdings in Q2 2026
5 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Arcus Biosciences Inc. | RCUS | Healthcare | 58.76% | 31,424,760 | - | - | $968,825,351 |
| Lakefront Biotherapeutics | GLPG | Healthcare | 30.34% | 16,707,477 | - | - | $500,157,715 |
| Assembly Biosciences Inc. | ASMB | Healthcare | 8.30% | 4,977,089 | +471,698 | +10.47% | $136,770,406 |
| Kyverna Therapeutics Inc. | KYTX | Healthcare | 2.23% | 4,126,119 | - | - | $36,763,720 |
| Xilio Therapeutics Inc. | XLO | Healthcare | 0.38% | 650,389 | - | - | $6,230,727 |